Mantlo E - Search Results

1

Antiviral activities of type I interferons to SARS-CoV-2 infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811. Epub 2020 Apr 29. Antiviral Res. 2020. PMID: 32360182 Free PMC article.

2

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.

Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S. Radosevic D, et al. Among authors: mantlo e. Front Cell Infect Microbiol. 2019 Mar 26;9:67. doi: 10.3389/fcimb.2019.00067. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30972303 Free PMC article.

3

Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.

Mantlo E, Paessler S, Huang C. Mantlo E, et al. Vaccines (Basel). 2019 Oct 2;7(4):138. doi: 10.3390/vaccines7040138. Vaccines (Basel). 2019. PMID: 31581720 Free PMC article. Review.

4

In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine.

Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S. Matejin S, et al. Among authors: mantlo e. Antivir Ther. 2019;24(8):589-593. doi: 10.3851/IMP3348. Antivir Ther. 2019. PMID: 32108589

5

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. bioRxiv [Preprint]. 2020 Apr 5:2020.04.02.022764. doi: 10.1101/2020.04.02.022764. bioRxiv. 2020. Update in: Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811 PMID: 32511327 Free PMC article. Updated. Preprint.

6

Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2.

Mantlo E, Evans A, Patterson-Fortin L, Boutros J, Smith R, Paessler S. Mantlo E, et al. bioRxiv [Preprint]. 2020 May 8:2020.05.08.082701. doi: 10.1101/2020.05.08.082701. bioRxiv. 2020. PMID: 32511363 Free PMC article. Preprint.

7

Luminore CopperTouch™ surface coating effectively inactivates SARS-CoV-2, Ebola and Marburg viruses in vitro.

Mantlo EK, Paessler S, Seregin A, Mitchell A. Mantlo EK, et al. medRxiv [Preprint]. 2020 Jul 14:2020.07.05.20146043. doi: 10.1101/2020.07.05.20146043. medRxiv. 2020. Update in: Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0139020. doi: 10.1128/AAC.01390-20 PMID: 32699857 Free PMC article. Updated. Preprint.

8

In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation.

Mantlo E, Rhodes T, Boutros J, Patterson-Fortin L, Evans A, Paessler S. Mantlo E, et al. F1000Res. 2020 Jul 3;9:674. doi: 10.12688/f1000research.24651.2. eCollection 2020. F1000Res. 2020. PMID: 33123349 Free PMC article.

9

Luminore CopperTouch Surface Coating Effectively Inactivates SARS-CoV-2, Ebola Virus, and Marburg Virus In Vitro.

Mantlo EK, Paessler S, Seregin A, Mitchell A. Mantlo EK, et al. Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0139020. doi: 10.1128/AAC.01390-20. Epub 2021 Jun 17. Antimicrob Agents Chemother. 2021. PMID: 33903111 Free PMC article.

10

Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.

Mantlo EK, Maruyama J, Manning JT, Wanninger TG, Huang C, Smith JN, Patterson M, Paessler S, Koma T. Mantlo EK, et al. J Virol. 2022 Apr 27;96(8):e0020922. doi: 10.1128/jvi.00209-22. Epub 2022 Mar 28. J Virol. 2022. PMID: 35343792 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters